Ortega Janice, Li Jessie Y, Lee Sanghee, Tong Dan, Gu Liya, Li Guo-Min
Department of Toxicology and Cancer Biology, Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY 40536;
Paul Laurence Dunbar High School, Lexington, KY 40513; and.
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5667-72. doi: 10.1073/pnas.1417711112. Epub 2015 Mar 30.
Proliferating cell nuclear antigen (PCNA) plays essential roles in eukaryotic cells during DNA replication, DNA mismatch repair (MMR), and other events at the replication fork. Earlier studies show that PCNA is regulated by posttranslational modifications, including phosphorylation of tyrosine 211 (Y211) by the epidermal growth factor receptor (EGFR). However, the functional significance of Y211-phosphorylated PCNA remains unknown. Here, we show that PCNA phosphorylation by EGFR alters its interaction with mismatch-recognition proteins MutSα and MutSβ and interferes with PCNA-dependent activation of MutLα endonuclease, thereby inhibiting MMR at the initiation step. Evidence is also provided that Y211-phosphorylated PCNA induces nucleotide misincorporation during DNA synthesis. These findings reveal a novel mechanism by which Y211-phosphorylated PCNA promotes cancer development and progression via facilitating error-prone DNA replication and suppressing the MMR function.
增殖细胞核抗原(PCNA)在真核细胞的DNA复制、DNA错配修复(MMR)以及复制叉处的其他事件中发挥着重要作用。早期研究表明,PCNA受翻译后修饰调控,包括表皮生长因子受体(EGFR)对酪氨酸211(Y211)的磷酸化。然而,Y211磷酸化的PCNA的功能意义仍不清楚。在此,我们表明EGFR介导的PCNA磷酸化改变了其与错配识别蛋白MutSα和MutSβ的相互作用,并干扰了MutLα核酸内切酶的PCNA依赖性激活,从而在起始步骤抑制MMR。我们还提供了证据表明Y211磷酸化的PCNA在DNA合成过程中诱导核苷酸错掺入。这些发现揭示了一种新机制,即Y211磷酸化的PCNA通过促进易出错的DNA复制和抑制MMR功能来促进癌症发展和进展。